Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma
Year: 2022
Type: article
Study design: Observational Study
Source: Gynecologic Oncology
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W4281719477
